Reversal by NGF of cytostatic drug-induced reduction of neurite outgrowth in rat dorsal root ganglia in vitro
Reference (57)
- et al.
Neurotrophin-5: a novel neurotrophic factor that activates trk and trkB
Neuron
(1991) - et al.
cis-Diamminedichloroplatinum (II) (cisplatin) alters microtubule assembly dynamics
Toxicol. Appl. Pharmacol.
(1992) - et al.
The neuromyopathy of vincristine in man: clinical, electrophysiological and pathological studies
J. Neurol. Sci.
(1970) - et al.
The trk tyrosine protein kinase mediates the mitogenic properties of nerve growth factor and neurotrophin-3
Cell
(1991) - et al.
Characteristics of the retrograde axonal transport system for nerve growth factor in the sympathetic nervous system
Brain Res.
(1974) Taxol-induced polymerization of purified tubulin. Mechanisms of action
J. Biol. Chem.
(1981)- et al.
Essential role of the nerve growth factor in the survival and maintenance of dissociated sensory and sympathetic nerve cells in vitro
Dev. Biol.
(1963) - et al.
Microtubule arrays in taxol-treated mouse dorsal root ganglion-spinal cord cultures
Brain Res.
(1981) - et al.
Morphological alterations in dorsal root ganglion neurons and supporting cells of organotypic mouse spinal cord-ganglion cultures exposed to taxol
Neuroscience
(1983) - et al.
Binding of brain-derived neurotrophic factor to the nerve growth factor receptor
Neuron
(1990)
Novel roles for neurotrophins are suggested by BDNF and NT-3 mRNA expression in developing neurons
Neuron
Single microtubules from squid axoplasm support bidirectional movement of organelles
Cell
trkB encodes a functional receptor for brain-derived neurotrophic factor and neurotrophin-3 but not nerve growth factor
Cell
Specificity of retrograde transport of nerve growth factor (NGF) in sensory neurons: A biochemical and morphological study
Brain Res.
Retrograde axonal transport of nerve growth factor: specificity and biological importance
Brain Res.
Gene expression of high-(p140trk) and low-affinity nerve growth factor receptor (LNGFR) in the adult and aged human peripheral nervous system
Neurosci. Lett.
Nerve growth factor regulates both the phosphorylation and steady-state levels of microtubule-associated protein 1.2 (MAP 1.2)
J. Cell. Biol.
Nerve growth factor prevents experimental cisplatin neuropathy
Ann. Neurol.
Nerve growth factor prevents toxic neuropathy in mice
Ann. Neurol.
Initial clinical experience from leurocristine, a new alkaloid from Vinca rosea Linn.
Association of125I-nerve growth facor with PC12 pheochromocytoma cells: Evidence for internalization via high-affinity receptors only and for long term regulation by nerve growth factor of both high and low affinity receptors
J. Biol. Chem.
Regulation of microtubule composition and stability during nerve growth factor-promoted neurite outgrowth
Vincristine neuropathy: clinical and electrophysiological observations
Brain
Gene transfer and molecular cloning of the human NGF receptor
Science
Neurotoxicology of vincristine in the cat: morphological study
Arch. Toxicol.
Enhanced dependence of fetal mouse neurons on trophic factors after taxol exposure in organotypic cultures
The role of microtubules in the growth and stabilization of nerve fibers
Ann. NY Acad. Sci.
Nerve growth factor-induced neurite outgrowth in PC12 cells involves the coordinate induction of microtubule assembly and assembly-promoting factors
J. Cell. Biol.
Cited by (69)
Pathogenesis of paclitaxel-induced peripheral neuropathy: A current review of in vitro and in vivo findings using rodent and human model systems
2020, Experimental NeurologyCitation Excerpt :Based upon some early in vivo work, whereby NGF administration alleviated the neurotoxic effects of paclitaxel administration to rodents (Apfel et al., 1991), investigators endeavored to overcome the degenerative effects of chemotherapeutics by increasing growth factors in the in vitro culture media (Chen et al., 2017; Konings et al., 1994; Malgrange et al., 1994; Pittman et al., 2016). Although a protective effect of NGF was observed in embryonic neuronal explants treated with paclitaxel (Konings et al., 1994), these findings were not replicated in dissociated neurons derived from adult rats (Pittman et al., 2016), thus there might be a contribution of development in the protective effects of NGF on neuronal morphology. Other neuroprotective agents that have been found to inhibit or counteract the morphological changes of neurons induced by paclitaxel or docetaxel include insulin-like growth factor-1 (Chen et al., 2017), minoxidil (Chen et al., 2017), erythropoietin (Maggioni et al., 2010; Melli et al., 2006), and pirenzepine (Calcutt et al., 2017).
Hormesis: A potential strategic approach to the treatment of neurodegenerative disease
2020, International Review of NeurobiologyCitation Excerpt :These include Activating Dependent Neutrotrophic Factor (ADNF) (Brenneman et al., 2005), allixin and various derivatives (Moriguchi et al., 1996a, 1996b, 1997), allopregnanolone (Gago et al., 2004; O'Neill et al., 2004; Wang et al., 2005), various cannabinoids (Nagayama et al., 1999), and BDNF (Boyd and Gordon, 2002), bisphenol A (Gursoy et al., 2001), DHEA (Marx et al., 2000), fluvoxamine (Takebayashi et al., 2002) glucocorticoids (Abraham et al., 2000, 2001), glutamate (Bambrick et al., 1995), imipramine (Takebayashi et al., 2002), L-DOPA (levodopa) (Mena et al., 1997), lisuride (Gille et al., 2002), NMDA antagonists, such as AP5 and MK801 (Brenneman et al., 1990a), NO (Kim et al., 1999), raloxifene (O'Neill et al., 2004), spermine (Abe et al., 1993), VCF (Sondell et al., 1999), and VDH (Brewer et al., 2001). Furthermore, several agents have been shown to have hormetic-like biphasic dose responses for neurite outgrowth, including arachidonic acid (Konings et al., 1994), EPO (Bocker-Meffert et al., 2002), FGF (Williams et al., 1994a, 1994b), melanocortins (Joosten et al., 1995), NGF (Rosoff et al., 2004), VEGF (Sondell et al., 1999) and the immunosuppressive agents cyclosporin and staurosporine (Costantini and Isacson, 2000). Also well, low doses of the neurotoxic agents 6-OHDA (Kulich and Chu, 2001), mercuric chloride (HgCl) and methylmercury (Toimela and Tahti, 2004), and several pyrethroid mixtures (Kakko et al., 2004) have been shown to enhance markers of neuronal survival.
Nerve growth factor alters microtubule targeting agent-induced neurotransmitter release but not MTA-induced neurite retraction in sensory neurons
2016, Experimental NeurologyCitation Excerpt :Our findings demonstrate that NGF, even at a supraphysiological concentration (250 ng/ml), does not prevent or attenuate the effects of MTAs to decrease neurite length and branching in mature adult sensory neurons. These findings contrast with previous reports, which demonstrate an NGF-dependent reversal of the effects of MTAs when examining neurite outgrowth from embryonic DRG explants, adult superior cervical ganglion explants, or adult dissociated DRG cultures (Konings et al., 1994; Malgrange et al., 1994; Hayakawa et al., 1998). Importantly, we investigated the effects of the MTAs and NGF to alter retraction or degeneration from mature neurites of neurons derived from adult animals, whereas other studies have focused on neurite outgrowth from the soma of recently axotomized neurons.
The neuroprotective effect of tropisetron on vincristine-induced neurotoxicity
2014, NeuroToxicology